BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 4369487)

  • 21. Antigenic modification of attenuated Sabin type 1 poliovirus by in vitro passages at supraoptimal temperatures.
    Crainic R; Blondel B; Candréa A; Dufraisse G; Horaud F
    Dev Biol Stand; 1985; 60():343-7. PubMed ID: 2995173
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Antibody status one year after the completion of a cycle of immunization with Sabin's oral poliomyelitis vaccine].
    Assumma M; Russo V; Alemanno A
    Arch Ital Sci Med Trop Parassitol; 1967; 48(7):175-86. PubMed ID: 5615073
    [No Abstract]   [Full Text] [Related]  

  • 23. Sabin and Salk poliovirus vaccine: vice versa.
    Cohen HH
    Acta Leiden; 1987; 56():65-83. PubMed ID: 3329800
    [No Abstract]   [Full Text] [Related]  

  • 24. A seroprevalence study of poliovirus antibody against a collection of recombinant and non-recombinant poliovirus vaccine strains in the population of southern Greece.
    Pliaka V; Ruether IG; Kyriakopoulou Z; Kioussi P; Plakokefalos E; Megalou M; Pratti A; Levidiotou-Stefanou S; Markoulatos P
    Clin Microbiol Infect; 2010 Nov; 16(11):1672-5. PubMed ID: 20148919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recommendations for a national policy on poliomyelitis vaccination.
    Nightingale EO
    N Engl J Med; 1977 Aug; 297(5):249-53. PubMed ID: 195207
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polio immunization.
    Tulchinsky TH; Goldblum N
    N Engl J Med; 2001 Jan; 344(1):61-2; author reply 62-3. PubMed ID: 11187114
    [No Abstract]   [Full Text] [Related]  

  • 27. [Behavior of poliovirus neutralizing antibodies in 108 subjects vaccinated with the Sabin vaccine].
    Andreoni G; Curatolo D; Cervini E; Rocchi G; Velli V
    G Mal Infett Parassit; 1966 Oct; 18(10):653-7. PubMed ID: 5997193
    [No Abstract]   [Full Text] [Related]  

  • 28. Poliovirus-specific memory immunity in seronegative elderly people does not protect against virus excretion.
    Abbink F; Buisman AM; Doornbos G; Woldman J; Kimman TG; Conyn-van Spaendonck MA
    J Infect Dis; 2005 Mar; 191(6):990-9. PubMed ID: 15717277
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Vaccination against poliomyelitis in France. 1983 experience and new trends].
    Celers J
    Ann Pediatr (Paris); 1984 Jun; 31(6):471-5. PubMed ID: 6465800
    [No Abstract]   [Full Text] [Related]  

  • 30. Decision analysis in planning for a polio outbreak in the United States.
    Jenkins PC; Modlin JF
    Pediatrics; 2006 Aug; 118(2):611-8. PubMed ID: 16882814
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Re: world wide experience with inactivated poliovirus vaccine.
    Arya SC; Agarwal N
    Vaccine; 2009 Jan; 27(1):1. PubMed ID: 18952133
    [No Abstract]   [Full Text] [Related]  

  • 32. [Control of poliomyelitis. I. Retrospective view and current situation in the world with special reference to our country].
    Vecchi C
    Ann Sclavo; 1972; 14(6):665-93. PubMed ID: 4360237
    [No Abstract]   [Full Text] [Related]  

  • 33. [A forgotten chapter of Mexican technology and science: Luis Gutiérrez Villegas and poliomyelitis in Mexico].
    Velázquez-Arellano A
    Gac Med Mex; 2017; 153(5):633-640. PubMed ID: 29099101
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of reversions in the 5'-untranslated region of attenuated poliovirus after sequential administration of inactivated and oral poliovirus vaccines.
    Laassri M; Lottenbach K; Belshe R; Rennels M; Plotkin S; Chumakov K
    J Infect Dis; 2006 May; 193(10):1344-9. PubMed ID: 16619180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibody response of children immunized with poliovaccines: an evaluation using two strains of poliovirus type 1.
    Deshpande JM; Dave KH
    Indian J Med Res; 1992 Sep; 95():216-20. PubMed ID: 1335965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The final stages of the global eradication of polio.
    John TJ
    N Engl J Med; 2000 Sep; 343(11):806-7. PubMed ID: 10984572
    [No Abstract]   [Full Text] [Related]  

  • 37. Prevalence of poliovirus neutralizing antibodies in young adult women.
    Mayer TR; Balfour HH
    JAMA; 1981 Sep; 246(11):1207-9. PubMed ID: 6267329
    [No Abstract]   [Full Text] [Related]  

  • 38. Salk vs. Sabin controversy.
    Puliyel JM
    Indian Pediatr; 1987 Aug; 24(8):690. PubMed ID: 3443513
    [No Abstract]   [Full Text] [Related]  

  • 39. Trial of a supplemental dose of four poliovirus vaccines.
    Sutter RW; Suleiman AJ; Malankar P; Al-Khusaiby S; Mehta F; Clements GB; Pallansch MA; Robertson SE
    N Engl J Med; 2000 Sep; 343(11):767-73. PubMed ID: 10984564
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serosurvey for polio antibodies.
    Biberi-Moroeanu S; Munţiu A; Stoiculescu S
    Virologie; 1988; 39(4):241-5. PubMed ID: 2851206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.